Clinical Trials Browser

Phase 1 × Not yet recruiting × Burkitt Lymphoma × Clear all

NCT07539610 2026-04-20

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

Phase 1 Not yet recruiting

Burkitt Lymphoma, Lymphoma

NCT07532525 2026-04-16

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Phase 1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

NCT07234045 2025-11-18

A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

Phase 1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

NCT07113496 2025-08-13

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Phase 1 Not yet recruiting

LymphoidPlasma cell

Plasmablastic Lymphoma, Burkitt Lymphoma, Multiple Myeloma, Recurrence

NCT07043218 2025-06-29

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1 Not yet recruiting

Burkitt Lymphoma

NCT04595162 2020-10-20

A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Phase 1 Not yet recruiting

Burkitt Lymphoma